Similar articles

• [Cardiovascular analeptics in respiratory resuscitation].

  Voisin C, Wattel F, Gosselin B, Tonnel AB, Dewailly P. Voisin C, et al. Anesth Analg (Paris). 1969 Sep-Oct;26(5):763-9. Anesth Analg (Paris). 1969. PMID: 4391675 French. No abstract available.
• Vasopressor agents in shock.

  Moyer JH, Mills LC. Moyer JH, et al. Am J Nurs. 1975 Apr;75(4):620-5. Am J Nurs. 1975. PMID: 1039254
• [Indications, in anesthesia and resuscitation, for various analeptics during cardiogenic shock].

  Lekieffre J. Lekieffre J. Anesth Analg (Paris). 1969 Sep-Oct;26(5):723-31. Anesth Analg (Paris). 1969. PMID: 4312807 French. No abstract available.
• Vasopressor therapy in critically ill patients with shock.

  Russell JA. Russell JA. Intensive Care Med. 2019 Nov;45(11):1503-1517. doi: 10.1007/s00134-019-05801-z. Epub 2019 Oct 23. Intensive Care Med. 2019. PMID: 31646370 Review.
• Pharmacologic Agents for the Treatment of Vasodilatory Shock.

  Knotzer H, Poidinger B, Kleinsasser A. Knotzer H, et al. Curr Pharm Des. 2019;25(19):2133-2139. doi: 10.2174/1381612825666190704101907. Curr Pharm Des. 2019. PMID: 31272348 Review.